+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

2019 Ichthyosis Vulgaris Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025

  • ID: 4767721
  • Report
  • April 2019
  • Region: Global
  • 37 pages
  • VPA Research
1 of 3

FEATURED COMPANIES

  • Aldeyra Therapeutics Inc
  • Crown Laboratories Inc
  • GlaxoSmithKline Plc
  • Pierre Fabre Foundation
  • Stiris Research Inc
  • Therapeutics Inc
  • MORE
The global clinical trial report- “2019 Ichthyosis Vulgaris Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Ichthyosis Vulgaris. It presents in-depth analysis of Ichthyosis Vulgaris clinical trials across markets and companies. The research work is for providing complete understanding into trends in Ichthyosis Vulgaris.

The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.

It also segments the Ichthyosis Vulgaris clinical trials by:
  • Current Trial Status
  • Type of the trial
  • Sponsor Type
  • Enrollment Trends
  • Region
  • Countries
  • Trial Phase
The report also identifies the potential drug candidates under development for treatment of Ichthyosis Vulgaris

The research work is prepared through extensive and continuous research on Ichthyosis Vulgaris trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.

Report Scope and Coverage:
  • All major trials from 2010 to 2019 and planned trials are included in the report scope.
  • Drug candidates currently being researched for administering Ichthyosis Vulgaris patients are identified
  • The report includes panorama of Ichthyosis Vulgaris clinical trials across the globe
  • Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
  • Companies and universities focusing on Ichthyosis Vulgaris clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
  • Average Enrollment number, insights into enrollment trends, company wise enrollment are included
  • Both interventional and observational studies are analyzed
  • News and latest developments for the past one year are presented in the report
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aldeyra Therapeutics Inc
  • Crown Laboratories Inc
  • GlaxoSmithKline Plc
  • Pierre Fabre Foundation
  • Stiris Research Inc
  • Therapeutics Inc
  • MORE
1.1 List of Figures
1.2 List of Tables

2. Executive Summary
2.1 Ichthyosis Vulgaris Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Ichthyosis Vulgaris Clinical Trials by Region
2.2.2 Average Enrollment of Ichthyosis Vulgaris Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Ichthyosis Vulgaris Treatment, 2019

3. Region wise Ichthyosis Vulgaris Clinical Trials
3.1 Asia Pacific Ichthyosis Vulgaris Clinical Trials by Country
3.2 Europe Ichthyosis Vulgaris Clinical Trials by Country
3.3 North America Ichthyosis Vulgaris Clinical Trials by Country
3.4 Middle East and Africa Ichthyosis Vulgaris Clinical Trials by Country
3.5 South and Central America Ichthyosis Vulgaris Clinical Trials by Country

4. Ichthyosis Vulgaris Clinical Trial Trends
4.1 Start Year wise Ichthyosis Vulgaris Clinical Trials
4.2 Phase wise Ichthyosis Vulgaris Clinical Trials
4.3 Trial Status wise Ichthyosis Vulgaris Clinical Trials
4.4 Trial Type wise Ichthyosis Vulgaris Clinical Trials

5. Ichthyosis Vulgaris Average Enrollment Trends
5.1 Average Enrollment in Ichthyosis Vulgaris Trials by Year
5.2 Average Enrollment in Ichthyosis Vulgaris Trials by Phase
5.3 Average Enrollment in Ichthyosis Vulgaris Trials by Status
5.4 Average Enrollment in Ichthyosis Vulgaris Trials by Type of Trial

6. Companies Participating in Ichthyosis Vulgaris Clinical Trials
6.1 Ichthyosis Vulgaris Trials by Sponsor Type
6.2 Ichthyosis Vulgaris Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors

7. Trial Snapshots- Phase, Type, Title, Location, Start Year, Completion Year, Recruitment Status, Enrollment, Participating Countries, Trial Locations, Company, Drugs and Other Details
7.1 Ichthyosis Vulgaris Trials- Phase 1
7.2 Ichthyosis Vulgaris Trials- Phase 2
7.3 Ichthyosis Vulgaris Trials- Phase 3
7.4 Ichthyosis Vulgaris Trials- Phase 4

8. Appendix
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise

List of Figures
Figure 1: Ichthyosis Vulgaris Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Figure 5: Europe - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Figure 6: Middle East Africa - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Figure 7: North America - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Figure 8: South and Central America - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Figure 9: Ichthyosis Vulgaris Clinical Trials by Phase
Figure 10: Ichthyosis Vulgaris Clinical Trials by Trial Status
Figure 11: Ichthyosis Vulgaris Clinical Trials by Type
Figure 12: Ichthyosis Vulgaris Clinical Trials by Sponsor Type
Figure 13: Ichthyosis Vulgaris Clinical Trials by Leading Sponsors
Figure 14: Ichthyosis Vulgaris Average Enrollment by Phase
Figure 15: Ichthyosis Vulgaris Average Enrollment by Trial Status
Figure 16: Ichthyosis Vulgaris Average Enrollment by Type
Figure 17: Ichthyosis Vulgaris- Average Enrolment by Type of Sponsors
Figure 18: Ichthyosis Vulgaris- Enrolment by Leading Sponsors
Figure 19: Research Methodology

List of Tables
Table 1: Ichthyosis Vulgaris Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Table 5: Europe - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Table 6: Middle East Africa - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Table 7: North America - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Table 8: South and Central America - Country wise Ichthyosis Vulgaris Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Ichthyosis Vulgaris Average Enrollment by Phase
Table 15: Ichthyosis Vulgaris Average Enrollment by Trial Status
Table 16: Ichthyosis Vulgaris Average Enrollment by Type
Table 17: Ichthyosis Vulgaris- Average Enrolment by Type of Sponsors
Table 18: Ichthyosis Vulgaris- Enrolment by Leading Sponsors
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Adamis Pharmaceuticals Corp
  • Aldeyra Therapeutics Inc
  • Crown Laboratories Inc
  • GlaxoSmithKline Plc
  • Pierre Fabre Foundation
  • Stiris Research Inc
  • Therapeutics Inc
Note: Product cover images may vary from those shown
Adroll
adroll